Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01332097 | Safety & Efficacy of BCT197A2201 in COPD Patients Presenting With an Exacerbation | PHASE2 | COMPLETED | 183 | — | — | Mar 1, 2011 | May 1, 2013 | Mar 20, 2023 | - | — |
| Name | Type | Description |
|---|---|---|
| BCT197 | DRUG | - |
| Prednisone placebo | DRUG | capsules |
| BCT197 placebo | DRUG | capsules |
| Prednisone | DRUG | capsules |